The Health Service Executive (HSE) has acknowledged that current care services for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), are insufficient to meet patient needs in Ireland. Following years of advocacy from patient groups, the health service is now working to develop a new clinical model of care, though progress remains in the preliminary stages as officials evaluate existing service gaps and capacity requirements.
Current Service Limitations and Patient Experience
Patients living with ME/CFS in Ireland frequently report significant challenges in accessing specialized care. The condition, characterized by profound, persistent fatigue that does not improve with rest, often results in multi-system impairment. According to the HSE’s own service planning documents, the current infrastructure lacks a standardized, national pathway for diagnosis and long-term management.
Because ME/CFS is a complex, multi-faceted condition, patients often require coordinated care across various specialties, including immunology, neurology, and rehabilitation medicine. Currently, these services are fragmented. Many patients report long waiting times and a lack of primary care support, leaving them to manage debilitating symptoms—such as post-exertional malaise (PEM), cognitive dysfunction, and orthostatic intolerance—with limited medical oversight.
Development of a National Model of Care
The HSE has confirmed it is in the process of drafting a formal model of care to address these systemic deficits. This effort is designed to establish a consistent, evidence-based approach to managing ME/CFS across the country.
The initiative aims to:
- Standardize diagnostic criteria used by general practitioners and specialists.
- Improve access to multidisciplinary teams, including physical therapists, occupational therapists, and psychologists.
- Establish clear referral pathways between primary and secondary care settings.
While the HSE has admitted that current provision is inadequate, the timeline for the full implementation of this new model remains subject to ongoing workforce planning and resource allocation.
Clinical Challenges in Diagnosis and Management
Managing ME/CFS presents unique clinical hurdles. Unlike many chronic conditions, there is no single diagnostic blood test or biomarker currently available for routine clinical use. Diagnosis remains primarily clinical, based on the exclusion of other medical conditions that could account for the patient’s symptoms.
The National Institute for Health and Care Excellence (NICE) in the UK, whose guidelines are frequently referenced by international clinicians, emphasizes that care must be personalized and focused on energy management. This involves helping patients stay within their "energy envelope" to prevent the worsening of symptoms caused by physical or mental exertion. In Ireland, the transition toward this patient-centered approach is the primary goal of the emerging HSE framework.
Addressing the Care Gap
The acknowledgment by the HSE represents a shift in recognition for the patient community, which has long campaigned for formal, state-funded support. For those affected, the gap between the prevalence of the condition and the availability of specialized clinics has historically been wide.
As the HSE moves forward, the focus is expected to remain on balancing the need for specialized expertise with the necessity of supporting primary care physicians who are often the first point of contact for patients. The future of ME/CFS care in Ireland will likely depend on the successful integration of these services into the broader national health infrastructure, ensuring that patients receive timely, evidence-based interventions rather than fragmented support.